ConSeal International Incorporated v. Neogen Corporation

CourtDistrict Court, S.D. Florida
DecidedMay 14, 2020
Docket0:19-cv-61242
StatusUnknown

This text of ConSeal International Incorporated v. Neogen Corporation (ConSeal International Incorporated v. Neogen Corporation) is published on Counsel Stack Legal Research, covering District Court, S.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
ConSeal International Incorporated v. Neogen Corporation, (S.D. Fla. 2020).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF FLORIDA

Case No. 19-cv-61242-BLOOM/Valle

CONSEAL INTERNATIONAL INCORPORATED,

Plaintiff,

v.

NEOGEN CORPORATION,

Defendant. ________________________________/

ORDER THIS CAUSE is before this Court upon Plaintiff ConSeal International Inc.’s (“Plaintiff”) Motion for Leave to Amend Complaint to Add Party Defendant. ECF Nos. [32] & [35] (“Motion”). Defendant Neogen Corporation (“Defendant”) filed its Response in Opposition, ECF Nos. [39] & [43] (“Response”),1 to which Plaintiff replied, ECF No. [47] (“Reply”). The Court has carefully reviewed the Motion, the opposing and supporting submissions, all relevant exhibits, the record in this case, and the applicable law, and is otherwise fully advised. For the reasons set forth below, Plaintiff’s Motion is denied. I. BACKGROUND Plaintiff initiated the instant breach of contract action against Defendant on May 16, 2019. ECF No. [1] (“Complaint”). Plaintiff’s Complaint asserts five Counts: Count I – Breach of

1 Plaintiff initially filed a redacted Motion, ECF No. [32], which it later refiled under seal without redactions, ECF No. [35]. Likewise, Defendant filed a redacted version of its Response first, ECF No. [39], an unredacted version of which was later filed under seal, ECF No. [43]. The Court will reference and cite to the sealed and unredacted versions of these briefs, ECF Nos. [35] & [43], throughout the remainder of this Order. Contract; Count II – Open Account; Count III – Account Stated; Count IV – Promissory Estoppel; and Count V – Unjust Enrichment. See generally id. The facts relevant to the instant Motion are as follows: Plaintiff manufactures, produces, and sells various chemical products used for sanitizing and disinfecting livestock facilities, including a chlorine dioxide product under the tradename “MaxKlor.” Id. ¶¶ 9-10, 12. Beginning

in November 2009, Plaintiff entered into an informal agreement with Preserve, Inc. (“Preserve”) where Plaintiff would manufacture and deliver MaxKlor to Preserve for distribution and sale. Id. ¶¶ 11-13. In early 2015, Preserve indicated its desire to enter into a more formal agreement where Preserve would be the exclusive seller of MaxKlor products in certain market segments, which Plaintiff agreed to with the condition that Preserve would purchase a minimum amount of MaxKlor annually in exchange for exclusivity. Id. ¶ 14. Accordingly, around May 20, 2015, Plaintiff and Preserve entered into a formal, written agreement, ECF No. [1-3] (“License Agreement” or “Agreement”), that governed the manufacturing of MaxKlor products and the exclusive license granted to Preserve to distribute and sell these products. ECF No. [1] ¶¶ 15, 17. The Agreement’s

initial term was set to expire on December 31, 2019. Id. ¶ 16. In May 2016, Defendant, who markets and sells products in the food and animal safety industry, acquired all of Preserve’s stock and assets, including the License Agreement. Id. ¶ 21. As part of the acquisition, Neogen assumed the Licensed Agreement. Immediately after the acquisition, in May 2016, Neogen began purchasing the MaxKlor products from ConSeal and marketing, distributing and selling those products in accordance with the terms of the License Agreement. Neogen representatives also traveled to meet ConSeal representatives in person to discuss their continued relationship under the License Agreement. The parties have operated continuously and without objection since May 2016 with Neogen as the Licensee under the Agreement. Moreover, the License Agreement provides that “[t]his Agreement shall be binding upon, and shall inure to the benefit of, the parties and their respective Affiliates, successors, permitted assigns . . . .” License Agreement, § 13(l) (emphasis added). Id. ¶ 22. Defendant purchased MaxKlor products from Plaintiff until approximately July 2018, when Defendant notified Plaintiff that it was going to discontinue purchasing these products because it had found a cheaper alternative. Id. ¶¶ 23-24, 27-28. On or about November 8, 2018, Defendant sent Plaintiff a letter purporting to terminate the License Agreement because it wanted to find a cheaper alternative. Id. ¶ 29. Defendant has not purchased any MaxKlor products from

Plaintiff since July 2018, and therefore failed to meet its minimum annual purchase requirements. Id. ¶ 28. After being unable to reach a resolution pre-suit, Plaintiff filed this breach of contract action. On July 10, 2019, this Court issued an Order Setting Trial and Pre-trial Schedule, Requiring Mediation, and Referring Certain Matters to Magistrate Judge, ECF No. [18] (“Initial Scheduling Order”), which set the deadline to file all motions to amend pleadings on September 7, 2019. Id. at 1-2. Well after the amendment deadline had passed, the parties moved to extend the trial and pre-trial deadlines on two separate occasions, see ECF Nos. [26] & [28], both of which were granted, see ECF Nos. [27] & [29]. Finally, on April 27, 2020, after Plaintiff filed the instant

Motion, the Court granted the parties’ third request to extend the deadlines in this case, set the case for trial on September 14, 2020, and extended the discovery deadline until June 15, 2020, and the dispositive motion deadline until June 22, 2020. ECF No. [46] at 1-2 (“Final Scheduling Order”). In its Answer and Affirmative Defenses to Plaintiff’s Complaint, ECF No. [11] (“Answer”), filed on July 9, 2019, Defendant asserted affirmative defenses that Plaintiff’s Complaint fails to sufficiently allege that the Agreement was properly assigned to Defendant and this Agreement therefore is not enforceable against Defendant, that Preserve is an active, separate entity that is the only proper defendant in this case, and that Plaintiff failed to name or join Preserve, despite Preserve being an indispensable party and the only other party to the License Agreement. Id. at 23. Plaintiff states that it understood these defenses “to be nothing more than a postured technicality that, according to [Defendant], the assignment was ineffective because [Plaintiff’s] consent was somehow inadequate and the subject agreement was not enforceable against [Defendant].” ECF No. [35] at 2; see also id. at 7 (“[Plaintiff] understood that [Defendant’s] defense raised a technical legal issue of whether the Agreement was effectively

assigned to [Defendant], not a factual issue of whether or not [Defendant] had actually purchased MaxKlor at all.”). However, Plaintiff explains that it recently learned during discovery that Defendant is not merely contesting Plaintiff’s consent to the assignment, but that Preserve had been purchasing MaxKlor products during the entire relevant time period at issue in this case. Id. Specifically, on February 26, 2020, Defendant’s corporate representative testified at her deposition that “[Defendant] has never sold MaxKlor Products, [Defendant] has never purchased MaxKlor Products, [Defendant] has never received any revenue from the sale of MaxKlor Products and that money paid to [Plaintiff] for MaxKlor products came from Preserve.” Id. at 9; see also ECF No. [35-4] at 72:19-75:19.

On April 9, 2020, upon learning of Defendant’s position that Preserve was the only entity that purchased and sold MaxKlor products during the relevant time period, Plaintiff filed the instant Motion seeking the Court’s leave to amend its Complaint to add Preserve as a party defendant. See ECF No. [35]; see also ECF No. [35-18] (“Amended Complaint”). Defendant filed its Response on April 23, 2020, opposing the requested relief because amendment at this stage — after the deadline to amend pleadings has long passed — is both untimely and unduly prejudicial to Defendant and Preserve. See ECF No. [43].

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Max Saewitz v. Lexington Insurance Co.
133 F. App'x 695 (Eleventh Circuit, 2005)
Valpak Direct Marketing Systems v. Robert Maschino
349 F. App'x 368 (Eleventh Circuit, 2009)
George v. Smith v. School Board of Orange County
487 F.3d 1361 (Eleventh Circuit, 2007)
Oravec v. Sunny Isles Luxury Ventures, L.C.
527 F.3d 1218 (Eleventh Circuit, 2008)
Romero v. Drummond Co., Inc.
552 F.3d 1303 (Eleventh Circuit, 2008)
Southern Grouts & Mortars, Inc. v. 3M Co.
575 F.3d 1235 (Eleventh Circuit, 2009)
Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Everett Earl Thomas v. Town of Davie
847 F.2d 771 (Eleventh Circuit, 1988)
Moyer v. Walt Disney World Co.
146 F. Supp. 2d 1249 (M.D. Florida, 2000)
Tony E. Mathis v. City of Morrow, Georgia
601 F. App'x 805 (Eleventh Circuit, 2015)
Derek Quinn v. Deutsche Bank National Trust Company
625 F. App'x 937 (Eleventh Circuit, 2015)
Debra Morrissey v. ASD Shared Services, LLC, eta l
626 F. App'x 946 (Eleventh Circuit, 2015)
Donahay v. Palm Beach Tours & Transportation, Inc.
243 F.R.D. 697 (S.D. Florida, 2007)
De Varona v. Discount Auto Parts, LLC
285 F.R.D. 671 (S.D. Florida, 2012)
Sanchez v. H & R Maintenance, L.C.
294 F.R.D. 677 (S.D. Florida, 2013)
Arianas v. LVNV Funding LLC.
307 F.R.D. 615 (M.D. Florida, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
ConSeal International Incorporated v. Neogen Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/conseal-international-incorporated-v-neogen-corporation-flsd-2020.